$VSTM: Verastem Oncology Announces Publication of the Phase 2 …

Date: Thursday, February 14th, 2019

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: BOSTON–(BUSINESS WIRE)–Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and …

Full article address: https://www.businesswire.com/news/home/20190214005211/en/Verastem-Oncology-Announces-Publication-Phase-2-DYNAMO

Related News:

$VSTM $GF $MEIP: Hedge Funds Have Never Been This Bullish On Verastem Inc (VSTM)

$MRK $VSTM $INFI $TAK: Verastem Up on Positive Data From Early-Stage Copiktra Study

$VSTM: Verastem Shares Response Rate From COPIKTRA Data

$VSTM: Verastem unveils Copiktra data in peripheral T-cell lymphoma

$VSTM: Verastem Oncology Presents COPIKTRA™ (Duvelisib) Data in …

$VSTM: Verastem Oncology Announces Leadership Changes

$PFE $QURE $BPMC $ARRY $VSTM: Cancer/Gene Therapy Biotechs in Focus After Pfizer-Array Deal

$VSTM: Verastem Oncology to Present New COPIKTRA™ (Duvelisib) Dose …

$KEG $VSTM $SPRT $MAXR: Microcaps mostly among midday movers

$VSTM: Verastem Inc (VSTM) Q1 2019 Earnings Call Transcript

$VSTM: Verastem, Inc. (VSTM) CEO Robert Forrester on Q1 2019 Results …

Latest News:

$NLSN: Trump’s Meet the Press interview fails to deliver ratings bump for NBC

$BB $MU: Mid-Afternoon Market Update: Micron Technology Jumps On Upbeat …

$SBH: Sally Beauty Launches New Mobile App in Support of 15 Million …

$CBL: SHAREHOLDER ALERT: CBL TEVA: The Law Offices of Vincent …

$FDX $AMZN: Analysts: FedEx Still Poised to Deliver Growth, But Not Overnight

$EFX: Should You Investigate Equifax Inc. (NYSE:EFX) At US$131?

$ACER: Acer Therapeutics Inc.’s (NASDAQ:ACER) Path To Profitability

$SEE: SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of …

$M: Remodulin (treprostinil; United Therapeutics/Mochida) Overview …

$MYL $KSS: 6 Worst S&P 500 Stocks of 2019 (So Far)

$RF: Regions opens 19 new loan and deposit production offices